In line with the in vivo findings, the knockdown of PRRC2A suppressed CSNK1E expression in CRC cells, while its overexpression upregulated it (Figure 5G,H; Figure S6F, Supporting Information). This evidence concerns the gene PRRC2A and colorectal carcinoma.